PRS:创新!用于腹壁下动脉穿支(DIEP)皮瓣采集的全息可视化技术

2021-04-23 MedSci原创 MedSci原创

在腹壁下动脉穿支(DIEP)皮瓣移植过程中,腹壁动脉及其穿支的识别和定位至关重要。

在腹壁下动脉穿支(DIEP)皮瓣移植过程中,腹壁动脉及其穿支的识别和定位至关重要。 在腹壁下动脉穿支(DIEP)皮瓣手术中,必须确定患者腹壁动脉及其穿支的位置、大小和关系。获取患者腹部的计算机断层摄影血管造影照片或磁共振血管造影照片可以增强术前对手术部位的了解,并减少手术时间和可能的并发症。 全息增强现实是一种创新技术,可用于可视化直接从患者计算机断层扫描中提取的特定于患者的解剖结构。 该研究描述了实现这一点的创新工作流程,开发了一个微软全息透镜软件应用程序,将解剖结构可视化为全息图。 图1.带有穿孔器(白色箭头)和不透射线皮肤标记(灰色箭头)的计算机断层造影切片。 图2.从用户角度看全息透镜增强现实应用加载屏幕。 图3.为了使全息透镜将解剖全息图记录到肚脐上方的快速反应代码,腹部痣用全息透镜识别的不锈钢指针指示。 图4。当全息透镜通过肚脐上方的快速反应标记跟踪患者位置时,呈现解剖全息图。绿色圆柱体表示皮肤上的穿孔器位置。用户可以在不同解剖结构的可视化之间切换。 以腹部作为自然标志,记录患者的解剖全息图。为了确保当患者或用户移动时解剖全息图保持正确定位,通过将快速响应标记附在患者身上来

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2022-02-02 kzlchina
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2022-03-30 lsndxfj
  4. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-25 ms4000001321388123

    可以可以

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-25 sunylz
  7. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-25 lg.zhao
  8. [GetPortalCommentsPageByObjectIdResponse(id=1669081, encodeId=34581669081c9, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Wed Feb 02 06:04:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942863, encodeId=cb211942863ab, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Nov 29 12:04:31 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810577, encodeId=016618105e790, content=<a href='/topic/show?id=85e08554600' target=_blank style='color:#2F92EE;'>#腹壁下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85546, encryptionId=85e08554600, topicName=腹壁下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 30 09:04:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960380, encodeId=3ef0960380ce, content=可以可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/5bbdab89439f445fb1db1b7e538b5fdc/97a3781abad244cdbfa3acce653e81e2.jpg, createdBy=fb8a5485615, createdName=ms4000001321388123, createdTime=Sun Apr 25 15:34:52 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425649, encodeId=cca3142564972, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569666, encodeId=1045156966672, content=<a href='/topic/show?id=961b5945dd' target=_blank style='color:#2F92EE;'>#DIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5945, encryptionId=961b5945dd, topicName=DIE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d76015553894, createdName=lg.zhao, createdTime=Sun Apr 25 13:04:31 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959909, encodeId=08b7959909af, content=推动医学发展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Fri Apr 23 22:41:49 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 言西早

    推动医学发展。

    0

拓展阅读

PRS:胸背动脉穿支皮瓣在乳房再造中的应用

乳腺癌仍然是全世界女性中最常见的癌症。在过去的20年里,全国范围内的乳腺重建数量几乎翻了一番。在适当的指导和咨询下,患者现在可以选择两种主要类型的乳房再造: 自体或植入式。

在下肢重建中,穿支皮瓣血管作为受血动脉是否可靠?

穿支皮瓣为下肢重建带来了革命性的变革,它提供了单层薄而柔韧的覆盖,并具有极佳的美学匹配。

PRS:平均耗时小于30分钟,真皮下剥离提升纯皮穿支皮瓣和超薄皮瓣!

利用真皮作为剥离平面的标志进行远端至近端的剥离,可以简化单纯皮肤穿支皮瓣或超薄皮瓣的抬高。

PRS:浅筋膜提高术!一种更安全的超薄股前外侧穿支皮瓣切取技术

研究者忠于超薄的概念,试图使皮瓣解剖变得更简单、更安全,研究者描述了一种改良后的超薄股前外侧穿支皮瓣切取技术。

穿支皮瓣的类型及其临床应用

穿支皮瓣的概念由日本Koshima和Soeda于1989年首先提出,是指由穿支动静脉供养的岛状皮下组织皮瓣,属于轴型血管的皮瓣范畴。自1997年以来国际上每年召开一次穿支皮瓣培训交流大会,但直到2003年"根特"共识的发表,才引起世界学者的广泛重视。我国的穿支皮瓣概念由张世民等于2004年首先介绍。穿支皮瓣的概念曾在国内引起激烈争论,包括其基本的定义、命名、与传统皮瓣的关系等。笔者从穿支皮瓣的